Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

MYGN holding history

Myriad Genetics Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MYGN overviewAll 13F holders of MYGNFull Q2 2026 holdings

Shares (Q2 2026)
12,111
Value
$69.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MYGN by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,111$69.2K<0.1%−1,239−9.3%ReducedHolders
Q1 202613,350$60.1K<0.1%−4,347−24.6%ReducedHolders
Q4 202517,697$108.8K<0.1%+511+3.0%AddedHolders
Q3 202517,186$124.3K<0.1%−3,155−15.5%ReducedHolders
Q2 202520,341$108.0K<0.1%−747−3.5%ReducedHolders
Q1 202521,088$187.1K<0.1%−5,894−21.8%ReducedHolders
Q4 202426,982$369.9K<0.1%+2,933+12.2%AddedHolders
Q3 202424,049$658.7K<0.1%+4,909+25.6%AddedHolders
Q2 202419,140$468.2K<0.1%−4,853−20.2%ReducedHolders
Q1 202423,993$511.5K<0.1%+2,990+14.2%AddedHolders
Q4 202321,003$402.0K<0.1%+3,334+18.9%AddedHolders
Q3 202317,669$283.4K<0.1%−244−1.4%ReducedHolders
Q2 202317,913$415.2K<0.1%+724+4.2%AddedHolders
Q1 202317,189$399.3K<0.1%−2,109−10.9%ReducedHolders
Q4 202219,298$280.0K<0.1%+1,554+8.8%AddedHolders
Q3 202217,744$338.0K<0.1%+250+1.4%AddedHolders
Q2 202217,494$318.0K<0.1%−8,460−32.6%ReducedHolders
Q1 202225,954$654.0K<0.1%−5,128−16.5%ReducedHolders
Q4 202131,082$857.0K<0.1%+2,455+8.6%AddedHolders
Q3 202128,627$924.0K<0.1%−7,173−20.0%ReducedHolders
Q2 202135,800$1.09M<0.1%+4,146+13.1%AddedHolders
Q1 202131,654$964.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.